Legislation in states and in Washington could mean increased payments to Walgreens, CVS, Walmart and independent pharmacies ...

For a moment, it looked like Congress would actually enact reforms of controversial pharmacy benefit managers after several ...

Bank of America Securities analyst Allen Lutz has reiterated their bullish stance on CVS stock, giving a Buy rating on December 18.Pick the ...

The Justice Department has sued CVS Health, accusing the pharmaceutical giant of contributing to the opioid crisis by ...

The general mood among these heavyweight investors is divided, with 42% leaning bullish and 40% bearish. Among these notable ...

In addition to CVS's stock (CVS), those of others in the pharmacy-benefit-manager business have also suffered historically bad Decembers, including those of UnitedHealth Group Inc. (UNH) and Cigna ...

CVS has been hit with at least three federal class actions, including two antitrust cases accusing CVS Caremark Corp. and ...

Industry experts have noted that companies like CVS, which owns the pharmacy benefit manager Caremark, have significant control over prescription management in many states, including Michigan.

President-elect Trump wants to target pharmacy benefit managers. Congress is already on the case with a bill that could halve ...

Shares of health insurers fell after Trump called them middlemen who drive up costs and said he plans to eliminate their role ...

Members of the House Judiciary Committee last week announced an investigation of CVS Caremark for potential practices that ...

While asked at a press event about the drug industry, President-elect Trump is quoted as having said “we’re going to knock out the middle man,” ...